Same reason as when I came in on day 1 Tran. Sam reason as you. Its just bitterly disappointing that the company seems to have zero interest in its share price
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game